This product is for research use only, not for human use. We do not sell to patients.

Size | Price | Stock |
---|---|---|
1mg | $610 | In Stock |
2mg | $910 | In Stock |
5mg | $1310 | In Stock |
10mg | $2030 | In Stock |
100μg | $170 | In Stock |
500μg | $380 | In Stock |
Cat #: V83078 Purity ≥ 99%
Description: 13C,15N Tirzepatide is the 13C,15N-labelled form of Tirzepatide (LY-3298176; Mounjaro)(Tirzepatide internal standard), which is a first-in-class dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that has been approved by FDA in May 2022 for the treatment of type 2 diabetes.
Publications Citing InvivoChem Products
Product Promise

- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
Molecular Weight (MW) | 4842.38 (Sodium salt) |
---|---|
Molecular Formula | C219[13C]6H347N47[15N]1NaO68 |
Storage | Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
Synonyms | Tirzepatide internal standard |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.